FREIBURG IM BREISGAU, GERMANY - In 2022, the cancer agency of the World Health Organization (WHO) reported 20 million new cancer cases and 9.7 million deaths. The worldwide burden of cancer is expected to increase by approximately 50 percent in the next two decades, highlighting the urgent need to develop more targeted treatments.1
Traditional cancer treatments - including surgery, radiation therapy, chemotherapy, and immunotherapy - often have limited effectiveness because of their toxicity and restricted applicability. This has led to more research into personalized medicine, which aims to tailor treatments for every individual patient’s unique situation and therefore revolutionize cancer treatment in the coming years and decades.2
Cancer vaccines are a promising approach for personalized medicine
The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. Such content from The Yuan may be shared and reprinted but must clearly identify The Yuan as its original source. Content from a third-party copyright holder identified in the copyright notice contained in such third party’s content appearing in The Yuan must likewise be clearly labeled as such.